Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study

BACKGROUND: Stage IV gastric signet ring cell carcinoma (SRCC) is a type of malignant gastric cancer (GC) with poorer survival compared to metastatic non‐SRCC gastric cancer (NOS). However, chemotherapy alone was unable to maintain long‐term survival. This study aimed to evaluate survival benefit of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Tao, Song, Xueru, Liu, Qin, Yang, Yang, Yu, Lixia, Liu, Baorui, Wei, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792481/
https://www.ncbi.nlm.nih.gov/pubmed/31448584
http://dx.doi.org/10.1002/cam4.2521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792481/
https://www.ncbi.nlm.nih.gov/pubmed/31448584
http://dx.doi.org/10.1002/cam4.2521

Ejemplares similares